BOULE DIAGNOSTICS AB financials
BOULE DIAGNOSTICS AB
213800IK1TGY858TKZ45 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | SEK 558.5M | SEK 571.3M |
| Cost of sales | SEK 306.2M | SEK 321.6M |
| Gross profit | SEK 252.2M | SEK 249.7M |
| Administrative expenses | SEK 36.2M | SEK 32.7M |
| Operating profit (EBIT) | -SEK 349.7M | SEK 39.3M |
| Net finance income / (cost) | -SEK 11.1M | -SEK 9.2M |
| Finance costs | SEK 12.6M | SEK 11.3M |
| Profit before tax | -SEK 360.8M | SEK 30.1M |
| Income tax expense | -SEK 64.2M | SEK 5.1M |
| Profit for the year | -SEK 296.6M | SEK 25.0M |
| Total comprehensive income | -SEK 278.7M | SEK 13.2M |
| Per share | ||
| Basic EPS | SEK -7.64 | SEK 0.64 |
| Free cash flow / share | SEK 0.97 | SEK 1.14 |
| Cash flow statement | ||
| Cash generated from operations | SEK 48.5M | SEK 48.8M |
| Net cash from operating activities | SEK 46.6M | SEK 51.4M |
| Income taxes paid | SEK 5.7M | SEK 10.0M |
| Net cash from investing activities | -SEK 85.9M | -SEK 82.7M |
| Purchase of PP&E (capex) | SEK 8.9M | SEK 6.9M |
| Net cash from financing activities | SEK 24.4M | -SEK 25.5M |
| Proceeds from borrowings | -SEK 9.6M | -SEK 12.0M |
| Lease liability payments | SEK 14.0M | SEK 13.4M |
| Net change in cash | -SEK 14.9M | -SEK 56.8M |
| Balance sheet | ||
| Total assets | SEK 516.9M | SEK 755.1M |
| Non-current assets | SEK 262.1M | SEK 475.2M |
| Property, plant & equipment | SEK 39.5M | SEK 44.3M |
| Right-of-use assets | SEK 13.7M | SEK 23.5M |
| Intangible assets & goodwill | SEK 99.4M | SEK 379.0M |
| Current assets | SEK 254.8M | SEK 279.9M |
| Inventories | SEK 59.1M | SEK 62.4M |
| Trade & other receivables | SEK 173.0M | SEK 180.2M |
| Cash & equivalents | SEK 22.7M | SEK 37.3M |
| Total equity | SEK 196.4M | SEK 475.1M |
| — attributable to owners | SEK 196.4M | SEK 475.1M |
| Non-current liabilities | SEK 58.0M | SEK 77.0M |
| Lease liabilities (non-current) | SEK 1.1M | SEK 10.9M |
| Current liabilities | SEK 262.5M | SEK 203.0M |
| Lease liabilities (current) | SEK 13.2M | SEK 13.0M |
| Deferred tax liabilities | SEK 2.2M | SEK 4.9M |
| Derived metrics | ||
| Free cash flow | SEK 37.7M | SEK 44.5M |
| Operating margin | -62.6% | 6.9% |
| Net margin | -53.1% | 4.4% |
| Return on equity | -151.0% | 5.3% |
| Cash conversion ratio | -0.16× | 2.06× |
| Capex coverage | 5.23× | 7.48× |
| Other reported items | ||
| Additional Paidin Capital | SEK 336.2M | SEK 336.2M |
| Adjustments For Decrease Increase In Inventories | -SEK 2.9M | SEK 8.8M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -SEK 18.4M | -SEK 2.5M |
| Adjustments For Increase Decrease In Trade and Other Payables | SEK 9.9M | SEK 13.0M |
| Adjustments For Reconcile Profit Loss | SEK 415.1M | SEK 29.6M |
| Current Accruals and Current Deferred Income Including Current Contract Liabilities | SEK 53.7M | SEK 40.5M |
| Current Prepayments and Current Accrued Income Including Current Contract Assets | SEK 15.5M | SEK 11.9M |
| Current Provisions | SEK 1.2M | SEK 1.1M |
| Current Raw Materials and Current Production Supplies | SEK 29.1M | SEK 24.0M |
| Current Tax Assets Current | SEK 5.6M | SEK 7.8M |
| Current Tax Liabilities Current | SEK 8.9M | SEK 5.9M |
| Deferred Tax Assets | SEK 69.8M | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | SEK 279.0K | -SEK 2.8M |
| Equity and Liabilities | SEK 516.9M | SEK 755.1M |
| Finance Income | SEK 1.4M | SEK 2.2M |
| Financial Assets | SEK 53.4M | SEK 51.9M |
| Finished Goods | SEK 24.3M | SEK 33.2M |
| Gains Losses On Exchange Differences On Translation Net of Tax | SEK 17.9M | -SEK 11.8M |
| Gains Losses On Net Monetary Position | SEK 145.0K | -SEK 33.0K |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | SEK 33.5M | — |
| Intangible Assets Other Than Goodwill | SEK 7.5M | SEK 293.6M |
| Interest Paid Classified As Operating Activities | SEK 12.6M | SEK 11.3M |
| Interest Received Classified As Operating Activities | SEK 1.4M | SEK 1.1M |
| Issued Capital | SEK 9.7M | SEK 9.7M |
| Liabilities | SEK 320.5M | SEK 280.0M |
| Longterm Warranty Provision | SEK 3.4M | SEK 3.4M |
| Machinery | SEK 13.6M | SEK 7.0M |
| Noncurrent Trade Receivables | SEK 49.6M | SEK 48.6M |
| Other Comprehensive Income | SEK 17.9M | -SEK 11.8M |
| Other Current Payables | SEK 24.5M | SEK 22.3M |
| Other Current Receivables | SEK 5.7M | SEK 6.7M |
| Other Noncurrent Assets | SEK 3.0M | SEK 3.9M |
| Other Noncurrent Financial Assets | SEK 3.8M | SEK 3.2M |
| Other Operating Income Expense | -SEK 6.6M | -SEK 4.0M |
| Other Property Plant and Equipment | SEK 9.2M | SEK 9.9M |
| Payments For Development Project Expenditure | SEK 77.0M | SEK 75.8M |
| Payments For Share Issue Costs | — | SEK 560.0K |
| Research and Development Expense | SEK 399.4M | SEK 53.1M |
| Reserve of Exchange Differences On Translation | SEK 48.5M | SEK 30.7M |
| Retained Earnings | -SEK 198.0M | SEK 98.5M |
| Selling Expense | SEK 126.2M | SEK 120.7M |
| Share Issue Related Cost | — | SEK 560.0K |
| Trade and Other Current Payables To Trade Suppliers | SEK 31.7M | SEK 35.7M |
| Work In Progress | SEK 5.7M | SEK 5.2M |
Every line item above is a fact tagged in BOULE DIAGNOSTICS AB's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (SEK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.